BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
+10.55%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$850M
AUM Growth
-$111M
(-12%)
Cap. Flow
-$85.6M
Cap. Flow
% of AUM
-10.07%
Top 10 Holdings %
Top 10 Hldgs %
87.63%
Holding
26
New
2
Increased
1
Reduced
5
Closed
–
Top Buys
| 1 |
Olema Pharmaceuticals
OLMA
|
+$43.6M |
| 2 |
UPB
Upstream Bio, Inc. Common Stock
UPB
|
+$37.7M |
| 3 |
NewAmsterdam Pharma
NAMS
|
+$6.3M |
Top Sells
| 1 |
Nuvalent
NUVL
|
+$97.9M |
| 2 |
Disc Medicine
IRON
|
+$51.5M |
| 3 |
Annexon
ANNX
|
+$16.4M |
| 4 |
Dianthus Therapeutics
DNTH
|
+$7.06M |
| 5 |
Nautilus Biotechnolgy
NAUT
|
+$405K |
Sector Composition
| 1 | Healthcare | 99.66% |